About AVT
Browse Articles
Authors
Customer Services

Advanced Publication

Antiviral Therapy publishes articles here before they are finally assigned to an issue. The articles are listed by online publication date and can be cited via a doi.
 
Displaying 65 results:

Original article

Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials

Ana Arias, Antonio Aguilera, Vicente Soriano, Laura Benítez-Gutiérrez, Gemma Lledó, Daniel Navarro, Ana Treviño, Esteban Otero, José M Peña, Valentín Cuervas-Mons, Carmen de Mendoza

10.3851/IMP3061


Case report

A case of a probable drug interaction between lurasidone and atazanavir-based antiretroviral therapy

Mark Naccarato, Elise Hall, Alan Wai, Mario Ostrowski, Adriana Carvalhal

10.3851/IMP3059


Case report

Elvitegravir/cobicistat-associated toxic optical neuropathy in an HIV-infected patient: a call for caution?

Agostino Riva, Alessandro Invernizzi, Chiara Resnati, Valeria Micheli, Dario Cattaneo, Cristina Gervasoni

10.3851/IMP3058


Original article

Resistance-associated variants in HCV subtypes 1a and 1b detected by Ion Torrent sequencing platform

Karine V Gaspareto, Roberto M Ribeiro, Fernanda de M Malta, Michele S Gomes-Gouvêa, Nair H Muto, Camila M Romano, Maria C Mendes-Correa, Flair J Carrilho, Ester C Sabino, João R Rebello Pinho

10.3851/IMP3057


Original article

Primer ID ultra-deep sequencing reveals dynamics of drug resistance-associated variants in breakthrough hepatitis C viruses: relevance to treatment outcome and resistance screening

Richard Barnard, Abha Chopra, Ian James, John Blinco, Mark W Watson, Cassandra B Jabara, Daria Hazuda, Stanley M Lemon, Simon Mallal, Silvana Gaudieri

10.3851/IMP3056


Original article

HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV–HIV-coinfected patients

Timothy NA Archampong, Ceejay L Boyce, Margaret Lartey, Kwamena W Sagoe, Adjoa Obo-Akwa, Ernest Kenu, Jason T Blackard, Awewura Kwara

10.3851/IMP3055


Original article

Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children

Adeodata Kekitiinwa, Victor Musiime, Margaret J Thomason, Grace Mirembe, Marc Lallemant, Sarah Nakalanzi, David Baptiste, A Sarah Walker, Diana M Gibb, Ali Judd

10.3851/IMP3054


Original article

Emergence of HCV resistance-associated variants in patients failing sofosbuvir-based regimens: an observational cohort

Elisabeth André-Garnier, Oliver Ribeyrol, Jerome Gournay, Bernard Besse, Marianne Coste-Burel, Isabelle Mabille-Archambeaud, Eric Billaud, Charlotte Biron, Solene Pineau, François Raffi, Berthe-Marie Imbert-Marcille

10.3851/IMP3053


Short communication

HIV viral suppression in TREAT Asia HIV Observational Database enrolled adults on antiretroviral therapy at the Social Health Clinic, the National Center for HIV/AIDS, Dermatology & STDs, Phnom Penh, Cambodia

David C Boettiger, Vohith Khol, Nicolas Durier, Matthew Law, Ly Penh Sun

10.3851/IMP3052


Original article

Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study

David A Kamara, Colette Smith, Lene Ryom, Peter Reiss, Martin Rickenbach, Andrew Phillips, Amanda Mocroft, Stephan De Wit, Matthew Law, Antonella d’Arminio Monforte, Francois Dabis, Christian Pradier, Jens D Lundgren, Caroline Sabin

10.3851/IMP3051


Page:
Copyright © Nucleus Global 2016. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.